TrialInternational journal of hematology2009

Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001.

Roberto H Nussenzveig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.